Inside eLife

Latest

1. Toward a New Open Access: The Gates Foundation policy refresh

   The Bill & Melinda Gates Foundation are shifting their focus toward preprints. What does that mean for grantees, for eLife and for Open Science?

2. Open Science: Why you should preprint your next paper

   What are preprints and how do they benefit you and your research community? Plus find tools that help you keep up with the preprint literature.
3. 1. Epidemiology and Global Health
   2. Medicine
   3. Cancer Biology

   Event Report: Symposium on the impact of the COVID-19 pandemic on cancer outcomes

   Watch seven eLife authors showcase their research from our recent Special Issue.

4. Early-Career Advisory Group: Applications open for candidates to join in 2024

   We’re looking to elect early-career researchers to seven vacancies opening this August.

5. eLife Magazine: 1000 Insights and counting

   From mapping the brain of fruit flies to the science behind kombucha, we look back at more than ten years of publishing Insight articles that explain the impact of a research paper in its field.

6. eLife Latest: April 2024 update on our actions to promote equity, diversity and inclusion

   This seventh report highlights our recent activities and planned actions for the next six months

7. Publishing with eLife: Submitting with our new model

   How do you submit your research to eLife’s new model and what questions should you ask before submitting?

8. eLife Magazine: 300 Feature Articles and counting

   Feature Articles in eLife cover research culture, diversity and inclusion, and a wide range of other topics related to science and research.

9. eLife Latest: 2024 update on the diversity of our editorial community

   Our most detailed report on the diversity of eLife's editorial board showcases three years of progress, as well as areas for further improvement.

10. Being Neurodivergent in Academia: Your tips, tools and resources

    A crowdsourced list of practical advice on how to navigate the research environment, from and for neurodivergent scientists.